BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

744 related articles for article (PubMed ID: 25359497)

  • 1. Lipid mediators in the resolution of inflammation.
    Serhan CN; Chiang N; Dalli J; Levy BD
    Cold Spring Harb Perspect Biol; 2014 Oct; 7(2):a016311. PubMed ID: 25359497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural resolution of inflammation.
    Freire MO; Van Dyke TE
    Periodontol 2000; 2013 Oct; 63(1):149-64. PubMed ID: 23931059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory and proresolving lipid mediators.
    Serhan CN; Yacoubian S; Yang R
    Annu Rev Pathol; 2008; 3():279-312. PubMed ID: 18233953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mediators and mechanisms in the resolution of infectious inflammation: evidence for vagus regulation.
    Serhan CN; de la Rosa X; Jouvene C
    J Intern Med; 2019 Sep; 286(3):240-258. PubMed ID: 30565762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways.
    Serhan CN
    Annu Rev Immunol; 2007; 25():101-37. PubMed ID: 17090225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New endogenous anti-inflammatory and proresolving lipid mediators: implications for rheumatic diseases.
    Yacoubian S; Serhan CN
    Nat Clin Pract Rheumatol; 2007 Oct; 3(10):570-9; quiz 1 p following 589. PubMed ID: 17906612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution.
    Fredman G; Serhan CN
    Biochem J; 2011 Jul; 437(2):185-97. PubMed ID: 21711247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition.
    Serhan CN; Libreros S; Nshimiyimana R
    Semin Immunol; 2022 Jan; 59():101597. PubMed ID: 35227568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maresins: Specialized Proresolving Lipid Mediators and Their Potential Role in Inflammatory-Related Diseases.
    Tang S; Wan M; Huang W; Stanton RC; Xu Y
    Mediators Inflamm; 2018; 2018():2380319. PubMed ID: 29674943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proresolving lipid mediators and mechanisms in the resolution of acute inflammation.
    Buckley CD; Gilroy DW; Serhan CN
    Immunity; 2014 Mar; 40(3):315-27. PubMed ID: 24656045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome.
    Serhan CN; Dalli J; Colas RA; Winkler JW; Chiang N
    Biochim Biophys Acta; 2015 Apr; 1851(4):397-413. PubMed ID: 25139562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution.
    Serhan CN; Chiang N; Dalli J
    Semin Immunol; 2015 May; 27(3):200-15. PubMed ID: 25857211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus.
    Serhan CN; Chiang N
    Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S200-15. PubMed ID: 17965751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specialized pro-resolving mediator network: an update on production and actions.
    Chiang N; Serhan CN
    Essays Biochem; 2020 Sep; 64(3):443-462. PubMed ID: 32885825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of lipoxins and resolvins in human leukocytes.
    Kahnt AS; Schebb NH; Steinhilber D
    Prostaglandins Other Lipid Mediat; 2023 Jun; 166():106726. PubMed ID: 36878381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins.
    Spite M; Serhan CN
    Circ Res; 2010 Nov; 107(10):1170-84. PubMed ID: 21071715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the use of specialized proresolving molecules in critical care offer a more focused approach to controlling inflammation than that of fish oils?
    Martindale RG; Warren MM; McClave SA
    Curr Opin Clin Nutr Metab Care; 2016 Mar; 19(2):151-4. PubMed ID: 26828585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not?
    Serhan CN
    Am J Pathol; 2010 Oct; 177(4):1576-91. PubMed ID: 20813960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases.
    Spite M; ClĂ ria J; Serhan CN
    Cell Metab; 2014 Jan; 19(1):21-36. PubMed ID: 24239568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling.
    Elajami TK; Colas RA; Dalli J; Chiang N; Serhan CN; Welty FK
    FASEB J; 2016 Aug; 30(8):2792-801. PubMed ID: 27121596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.